Form D · Biotechnology
INTELLIKINE, INC.
La Jolla, CA · CIK 0001466851
Offering snapshot reported Jul 2, 2009 · SEC filing
- Reported sold
- $16M Offering amount: $38.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2009 | Initial | $16,033,331 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-132390
Source: Form D, filed Jul 2, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ken Haas | Director |
| Karl D. Handelsman | Director |
| Michael F. Powell | Director |
| Troy Wilson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10931 N. Torrey Pines Road Ste 103
La Jolla, CA, 92037
La Jolla, CA, 92037